StonvexLoading…
StonvexStonvexStonvexCore line items from COCH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $39.00K | $241.00K | $166.00K | $124.00K |
Operating Income | $-5.96M | $-22.27M | $-15.88M | $-10.18M |
Net Income | $-4.35M | $-23.76M | $-17.17M | $-5.69M |
EPS (Diluted) | $-0.08 | $-1.23 | $-0.97 | $-0.62 |
Total Assets | $29.82M | $8.56M | $8.18M | $9.90M |
Total Liabilities | $19.27M | $20.32M | $15.71M | $39.76M |
Cash & Equivalents | $25.25M | $3.74M | $3.56M | $5.29M |
Free Cash Flow OCF − CapEx | Not available | $-18.38M | $-12.52M | $-8.19M |
Shares Outstanding | 68.93M | 23.26M | 21.52M | 21.52M |